CPM
SGYP

Chesapeake Partners Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Chesapeake Partners Management’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-173,100
Closed -$1.44M – 126
2015
Q2 		$1.44M Buy
173,100
+72,100
+71% +$349K 0.06% 115
2015
Q1 		$467K Buy
+101,000
New +$328K 0.02% 98

Other funds holding SGYP

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Chesapeake Partners Management's SGYP Position: Q2 2016 in Review

Chesapeake Partners Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2016, closing a stake of 208,100 shares — an estimated $574K sold.

Chesapeake Partners Management first reported a position in SGYP in Q2 2015 and held it in 4 quarters. The position peaked at $1.18M in Q4 2015. 134 funds tracked by Wall St. Rank hold SGYP as of Q2 2016.

  • Chesapeake Partners Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2016 after selling out during the quarter.
  • Chesapeake Partners Management sold 208,100 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2016, an estimated $574K.
  • Chesapeake Partners Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2015 and held it in 4 quarters.
  • Chesapeake Partners Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.18M in Q4 2015.
  • 134 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2016.

Based on Chesapeake Partners Management's 13F filing for Q2 2016, filed 15 Aug 2016.